Percutaneous Coronary Intervention Market Share, Overview, Segmentation, Vendor Landscape and

Global Percutaneous Coronary Intervention Market Share and Growth by Product Type (Coronary Stents, PTCA Catheters, Coronary Guidewire and Accessories), by End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Research and Academic Institutes and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2023

Overview:Percutaneous Coronary Intervention Market Share is expected to reach over USD 15,205 million by 2023, growing at approximately 7.10% CAGR during the forecast period (2018-2023). The market stood at USD 10,160.9 million in 2017.

In recent years, the growing prevalence of chronic diseases related to heart, globally, the percutaneous coronary intervention market is growing at a rapid pace.  Moreover, the increasing adoption of PCI procedures performed on patients with coronary artery disease is escalating the market constantly.

Considering all these factors, the global percutaneous coronary intervention market is a non-invasive procedure used to treat narrowing arteries of the heart in coronary artery diseases including angina, acute myocardial infarction, and multivessel coronary artery disease (CAD), among others.  PCI procedure involving cardiac catheterization help in providing relief in the symptoms of coronary heart diseases and reduce damages to the heart after or during a heart attack.

In addition to the growing prevalence of coronary heart diseases, the ever-increasing population worldwide and the increasing demand for the quality healthcare systems are factors expected to propel market volume till 2023.

Moreover, risk factors causing the heart-related diseases such as the increasing inclination towards the heady & sedentary lifestyle, and wrong eating habits, and changes in the social system over the last few years have been accelerating the market growth, increasing the incidents of the disease related to the heart.

However, the stringent government regulations for the approval of medical devices used in PCI alongside the lack of awareness towards the availability of percutaneous coronary intervention procedure may hinder the market growth over the forecast period. Also, the potential implications in diagnosis such as the infection caused during the procedure that can be challenging to diagnose and may have severe consequences are affecting the market growth.

Regional Analysis:The Global Percutaneous Coronary Intervention Market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. Among these, the Americas region dominates the market attributing to the increasing pool of awareness and the growing acceptability of percutaneous coronary intervention techniques.  

The region accounted for almost 39% of the market share in 2017, followed by Europe accounting for 31% of the market share. Whereas, the Asia Pacific region can grow at a rapid clip mainly due to the increasing prevalence of cardiovascular diseases.  The region had accounted for around 23% of the market share.

The Americas region dominates the global percutaneous coronary intervention market mainly due to the higher health care expenditures and the increasing prevalence of diseases such as cardiovascular and coronary artery disease. Factors such as well-spread awareness and the growing adoption of percutaneous coronary intervention techniques are driving the growth of the PCI market in the Americas.

In the US, percutaneous coronary intervention is one of the two most common procedures performed on patients with coronary artery disease. The US backed by the growing prevalence of cardiovascular angiography and interventions accounts for the major growth supporter to the regional market. The percutaneous coronary intervention market in the Americas is expected to reach USD 4,894.7 million by 2023.

The Europe Percutaneous Coronary Intervention Market Share is projected to register over 6% CAGR during the forecast period valued at approximately 4,600 Mn USD by 2023. The region assumed the second position in 2017 globally due to the rise in percutaneous coronary intervention centers in European countries. Furthermore, the increased number of hospitalizations for percutaneous coronary intervention procedures such as carotid artery angioplasty and cerebral angioplasty have been fostering the regional market.

The Percutaneous Coronary Intervention Market in the Asia Pacific region is expected to emerge as a promising market, growing rapidly due to the increasing prevalence of cardiovascular diseases, rapidly developing healthcare infrastructure, and improving economic conditions in the region. Simultaneously, the increasing number of research and development centers positively impacts the growth of this market.

Furthermore, owing to the factors such as the government initiatives of healthcare reforms and the increasing demand for advanced treatments in the region, the percutaneous coronary intervention market in the APAC will reach the valuation of USD 3,620.3 million by 2023.

Segmentation:The Global Percutaneous Coronary Intervention Market has been segmented on the basis of product type and end-user.

Various product types are segmented into coronary stents, percutaneous transluminal coronary angioplasty (PTCA) catheters, coronary guidewires, and accessories. Among these, the subsegment coronary Stent accounted for the largest share of 54% share in 2017. It was valued at USD 5452.5 million in the same year. It is further projected to grow at a CAGR of 7.81% during the forecast period.

By End-user, the market has been segmented into hospitals & specialty clinics, ambulatory surgical centers, research & academic institutes, and others. Out of these, the subsegment hospitals & specialty clinics accounted for 43% of the market share in 2017 and valued at USD 4,374.9 million. The subsegment is estimated to continue with its dominance registering a CAGR of 7.57% over the assessment period. The large share can be credited to the mushrooming of hospital chains amid increasing demands for quality patient care.

Competitive Dashboard:Prominent players operating in the percutaneous coronary intervention market include Boston Scientific Corporation (U.S.), Abbott (U.S.), ASAHI INTECC Company Limited (Japan), C. R. Bard, Inc (U.S.), Comed B.V. (The Netherlands), Meril Lifesciences Pvt Ltd. (India), BIOTRONIK (U.S.), Medtronic Plc (U.S.), B. Braun Melsungen AG (Germany), Biosensors International Group, Ltd. (Singapore), Terumo Corporation (Japan), Cordis (U.S.), Cook Medical (U.S.), and Merit Medical System (U.S.).

Strategic initiatives employed often involve mergers, acquisitions, product launches, and others. These tactical moves ensure individual company’s growth alongside the market’s expansion.

Browse More Healthcare Related Research Reports at:

Blood Glucose Test Strip Packaging Market– Forecast to 2021 | MRFR

Clinical Intelligence Market Research Report- Forecast to 2023 | MRFR

Labyrinthitis Market Size, Growth Analysis | Industry Trends, 2023

About Market Research Future: 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Facial Injectors Market Share, Profile, Growth Impact and Demand by Regions

Facial Injectors Market Share, Size and Growth By Type (Dermal Fillers/Injectable Implants, Hyaluronic Acid, Synthetic Fillers, Collagen Fillers, Anti-Aging/Anti-Wrinkle Injections, Botulinum Toxin A, Poly-L-Lactic Acid (PLLA) Microparticles), By Application (Facial Line Correction Treatment, Face-Lift, Lip Treatments), By End-User (Dermatology Clinics & Cosmetic Centers, Hospitals), By Region (Americas, Europe, Asia Pacific and The Middle East & Africa) – Global Forecasts till 2023

Market Research Future (MRFR) has recently published a detailed report stating that the global facial injectors market share is set to expand at a significant CAGR of 11.12% during the forecast period from 2018 to 2023 and reach the valuation of USD 14571.47 Mn by the end of the forecast period from USD 7740.16 Mn in the year 2017. Incorporation of advanced technology in the healthcare sector has led to significant improvement in the procedures of cosmetic surgery and facial aesthetic treatment. Consumer preference towards minimally invasive treatments and rise in popularity of facial aesthetic treatments are fueling the demand for facial injectors, which in turn is leading to the noteworthy expansion of the global facial injectors market.

Booming entertainment industry and popularity of celebrity culture are not only affecting the lifestyle of the urban population but also raising the bar higher for beauty standards. Increased research for the development of advanced aesthetic injectors such a soft tissue filler and rise in demand for anti-aging and other beauty treatments in the emerging economies are some other important factors that are propelling the growth of the global facial injectors market. However, side-effects related to the materials used as injectors, serious complications arising during the surgical procedures and availability of black market for facial injectors are likely to act as restraining factors on the growth of the global facial injectors market during the forecast period. Whereas, increasing awareness and acceptance of combination therapies are expected to drive the growth of the global facial injectors market during the assessment period.

Key Players:

Some of the major players profiled by MRFR that are operating in the global facial injectors market are SciVision Biotech Inc, Ipsen Pharma. Merck KGaA, Sanofi, Revance Therapeutics Inc., Sinclair Pharma, Galderma S.A., Suneva Medical Inc., Merz Pharma, Valeant Pharmaceuticals, Allergan, and Integra LifeSciences Corporation.

Detailed Regional Analysis:

The Global facial injectors market has been covered across four major regions such as Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The market in Americas is anticipated to spearhead the global facial injectors market during the forecast period. By the end of 2023, the Americas facial injectors market size is expected to reach the valuation of 6339.94, reflecting a healthy CAGR of 10.83%. Rise in popularity of facial aesthetic treatment, increasing disposable income and availability of high-quality treatment with the incorporation of advanced cosmetic technology are primarily contributing to the expansion of the facial injectors market in this region. Meanwhile, the market in the Asia Pacific region is set to record the strongest CAGR of 12.02% during the review period. Booming entertainment industry is influencing the population in the emerging economies to undergo cosmetic surgeries, coupled with increased disposable income, which in turn is resulting in the significant expansion of the facial injectors market in the Asia Pacific region.

Segmental Analysis:

MRFR's report provides an in-depth segmental analysis of the global facial injectors market on the basis of type, application, end-user, and region. Based on type, the facial injectors market has been segmented into dermal fillers/ injectable implants and anti-aging/ anti-wrinkle injections. The dermal fillers/ injectable implants segment accounted for the largest share and is projected to maintain its dominance over the global facial injectors market with the valuation of USD 7934.80, expanding at a CAGR of 11.61%. The dermal fillers/ injectable implants segment has been sub-segmented into hyaluronic acid, synthetic fillers, and collagen fillers. Among these, the hyaluronic acid segment is leading with a significant CAGR of 11.69% in the global facial injectors market. The anti-aging/ anti-wrinkle injections segment has been sub-segmented into botulinum toxin A& poly-L-lactic acid (PLLA) microparticles.

Based on application, the facial injectors market has been segmented into facial line correction treatment, face-lift, lip treatment, and others. The facial line correction treatment segment touted to generate maximum revenue at a CAGR of 10.43%, with the valuation of USD 6382.84 Mn by 2023. Whereas, the face-lift segment is anticipated to project significant expansion at highest CAGR in the global facial injectors market during the assessment period.

Based on end-users, the market has been segmented into dermatology clinics & cosmetic centers, hospitals, and others. The dermatology clinics & cosmetic centers segment currently holds the pole position and is projected to surpass the valuation of USD 6061.35 Mn by 2023, at a CAGR of 10.78% during the forecast period.

Browse More Healthcare Related Research Reports at:

Americas Respiratory Therapeutic Devices Market– Forecast to 2020 | MRFR

Asia Pacific Healthcare Archiving and eDiscovery Market Research Report- Forecast to 2023 | MRFR

Hybrid Operating Room Market Size Analysis, Trends | Application, 2023

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Leukapheresis Products Market Size, Study of Key Players, Applications and Types,

Global Leukapheresis Products Market Share By Type (Leukapheresis Devices, Leukapheresis Disposables), by Application (Research Applications, Therapeutic Applications), By End User (Blood Component Provider and Blood Center, Other) -Forecast Till 2023

Market Highlights:

Leukapheresis is a laboratory procedure in which white blood cells (WBCs) are separated from a sample of blood. Leukapheresis is majorly carried out for chronic lymphocytic leukemia. It is anticipated that the leukapheresis products market share value of USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period.

 The factors such as increasing number of blood donations, rising prevalence of leukemia, and demand for leukapheresis products in clinical research are anticipated to propel the growth of the market over the forecast period. According to the National Institutes of Health (NIH) estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the period from 2006-2015. It also stated that the number of new cases may reach 60,300 in the year 2018. Despite the drivers, the high cost of therapeutic leukapheresis, dearth of skilled professionals, and stringent donor recruitment criteria may hamper the market growth over the assessment period.

Currently, many companies are operating in the global leukapheresis products market. The prominent players in the market are engaged in strategic collaborations, acquisitions, regional expansion, and new product launches to strengthen their market position. For instance, in February 2018, Terumo BCT entered into collaboration with Stafa Cellular Therapy. With this collaboration, Terumo BCT will act as a distributor for Stafa Cellular Therapy and will expand its access to StafaCT software to healthcare organizations.

Regional Analysis:

Geographically, the Americas is anticipated to dominate the global leukapheresis products market owing to the rising number of blood donations, and growing incidence and prevalence of leukemia. Europe is anticipated to hold the second largest position in the global leukapheresis products market. The market growth in this region is mainly due to the rising prevalence of leukemia and presence of well-developed healthcare sector in the region. Asia-Pacific region is expected to be fastest growing region due to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major pharma and biotech companies. The Middle East & Africa has the least global leukapheresis products market owing the poor healthcare infrastructure especially in the Africa region.

Segmentation:

The global leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.

The market, by application, has been segmented into research applications and therapeutic applications.

On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.

Key Players:

Some of the prominent players in the global leukapheresis products market are Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, and StemExpress

Browse More Healthcare Related Research Reports at:

Aphakia Market Research Report- Forecast to 2023 | MRFR

Americas Medical Rubber Balloon Products Market Research Report- Forecast to 2023 | MRFR

Americas Blood Glucose Test Strip Market Forecast to 2020 | MRFR

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hematology Diagnostics Market Share, Trends, Research, Growth

Hematology Diagnostics Market Share, Growth and Trends by Product Type (Hematology Analyzer, Flow Cytometer, Consumable), Tests (Hemoglobinopathy, Leukemia Phenotyping), End-User (Hospitals & Clinics, Diagnostic Laboratories) – Global Forecast Till 2023

Hematology Diagnostics Market – Overview:The renewed emphasis on health and wellness has prompted an increased focus on blood-related disorders as well. The hematology diagnostic market share is expected show positive CAGR during the forecast period. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. 

The increased prevalence of blood-related disorders is motivating the expansion of the hematology diagnostics market. Moreover, the development in the detection and diagnostic methods has improved the growth of the market for hematology diagnostics. The increased involvement of genetic diseases in blood-related ailments is projected to fuel the development of the hematology diagnostic market in the coming years.

Competitive Analysis:The growth of the market is moving in a favorable direction due to new product launches or rising gross revenue of the players in the market. Significant reductions in administrative costs are inducing further expansion of the market. The vertical additions and product tactics of the market are boosting the potential of the market players. The development of a robust value chain is further motivating the development of the market. The strategic goals intended for the market are reinforced due to favorable product differentiation carried out by market competitors.  Increased adaptability of market players to new market trends and customers inclinations are lifting the growth curve of the market and will continue do so in the forecast period. The successful implementation of strategies is expected to motivate the market in the coming years.

The central contenders in the hematology diagnostic market globally are Ortho Clinical Diagnostics (US), Danaher (US), Siemens (Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Abbott Laboratories (US), EKF Diagnostics (UK), Bio-Rad Laboratories (US), BioSystems (Spain), Sysmex (Japan), Diatron (Hungary), Nihon Kohden (Japan), Drew Scientific (US), Mindray (China), and Roche (Switzerland), and other.

Segmental Analysis:The segmental analysis of the hematology diagnostics market is segmented on the basis of tests, product type, and end-user. By product type, the hematology diagnostics market is segmented into flow cytometers, and consumables. The tests segment is additionally segmented into leukemia/lymphoma phenotyping, hemoglobinopathy, anemia, hematology pathophysiology, complete blood count (CBC) and others. Based on end-users, the market is segmented into ambulatory surgical centers, diagnostic laboratories, hospitals and clinics, academic institutes and others.    

Detailed Regional Analysis:The regional analysis of the hematology diagnostics market states that the North American region dominates the market due to the mounting incidence of blood diseases. The presence of the primary market players within the region is influencing the market growth. Factors such as growing healthcare expenditure, technological improvements within the population are driving the market development in this region. The European region is the subsequent market contender in the global hematology diagnostics market due to the growing hematology research within this region. The growing hematology research and government initiatives within this region are influencing the development of the hematology diagnostic market in this region.

The Asia Pacific region was recognized as the quickest rising region for the hematology diagnostics market globally in 2017. The market is projected to observe considerable development due to the intensifying commonness of blood disorders and genetic diseases. The predisposition of individuals in the region to genetic disorders due to marriages to blood relatives or marrying within the same community, ethnicity, caste, etc. The Middle Eastern and African region controls the smallest stake in the hematology diagnostics market globally owing to the incidence of strict government policies and deprived economies. Though, the market is projected to observe growth owing to increased investments by private market players in the Middle East. Moreover, the increasing incidence of genetic blood disorders and expanding government initiatives to develop the healthcare sector within the region is expected to contribute to the market’s growth.

Browse More Healthcare Related Research Reports at:

Image Guided Radiotherapy Market Size, Trends | Share Analysis, 2023

Central Pontine Myelinolysis Market Research Report- Forecast to 2023 | MRFR

EMEA Beauty Devices Market Size, Trends | Share Analysis, 2021

About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Cheilectomy Market Share, Analysis By Growth, Trend, Scope

Global cheilectomy market Share Analysis, Size and Growth by method (open, arthroscopic, percutaneous) anesthesia (general, local, and regional anesthesia) medication (prescription pain relievers, NSAIDs) end-users (academic institutes, clinics) – Forecast till 2023

Market Highlights

The global cheilectomy market share is expected to grow at an approximate CAGR of 7.8% during the forecast period. Factors like increasing prevalence of hallux rigidus, growing female population, rising demands for minimally invasive procedures, growing healthcare expenditure, and increasing geriatric population is estimated to drive the global cheilectomy market. However, high procedural cost, complications like deep vein thrombosis, need for repeated surgery, stiffness in the joints of the toes, and low per capita healthcare expenditure in the middle and low-income countries is estimated to restrain the market growth during the projected period.

Regional Analysis

The Americas dominate the global cheilectomy market. Well-developed healthcare sector, increasing prevalence of hallux rigidus, rising healthcare expenditure, and presence of the key players are some of the drivers for the market growth within the region. Additionally, increasing geriatric population and growing female population fuels the market growth.

Europe cheilectomy market share is the second largest. Increasing prevalence of osteoarthritis, growing geriatric population, and rising healthcare expenditures within the region are some of the driving factors for the market growth. On a regional basis, Europe is divided into two regions, i.e., Western Europe and Eastern Europe. Western Europe is estimated to be the leading market within the region.

Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India & China, and presence of huge opportunity in the market. On the other hand, the Middle East & Africa has the least share in the global cheilectomy market due to the presence of poor economies which have low per capita healthcare expenditure and stringent government policies, especially in the Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Key Players

The key players for the global are Henry Schein, Inc. (U.S.), STEROID S.p.A. (Italy), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Sanofi (France), Janssen Pharmaceuticals, Inc. (Belgium), PurduePharma (U.S.), ALLERGAN (Republic of Ireland), Boehringer Ingelheim International GmbH (Germany), and others.

 Segmentation

The global cheilectomy market is segmented by the method, anesthesia, medication, and end-user.

By the method, the market is segmented into open, arthroscopic, and percutaneous method.

By the anesthesia, the market is categorized into general anesthesia, local anesthesia, and regional anesthesia. By the medication, the market is segmented into prescription pain relievers, OCT, and others. By prescription the pain relievers the market is segmented into corticosteroids, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. By the OCT drugs, the market is segmented into ibuprofen, naproxen, and others. By end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.

Browse More Healthcare Related Research Reports at:

Ureteral Obstruction Market Trends, Application | Share Analysis, 2023

Lichen Sclerosus Treatment Market Trends, Size Analysis | Applications, 2023

Antihistamine Drugs Market Size, Application | Growth Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Parathyroid Disorders Market Share, Profile, Segmentation, Vendor Landscape

Parathyroid Disorders Market Size, Application And Trends Analysis By Type (Hyperparathyroidism, Parathyroid Cancer, Hypoparathyroidism), Diagnosis (Blood Test, Imaging, Urine Test), Treatment (Surgery, Radiation Therapy, Drugs), End User – Global Forecast Till 2023

Market Highlights:

It is estimated that the parathyroid disorders market size is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023. Parathyroid hormone plays a significant role in regulating the metabolism of calcium, phosphate, and Vitamin D. The hyperparathyroidism, and hypoparathyroidism are the two most common parathyroid disorders.

A number of factors such as growing geriatric population, rising prevalence of parathyroid disorders, increasing government assistance, rising healthcare expenditure, improving regulatory framework, and rising funding and reimbursements are propelling the growth of the global parathyroid disorders market.

However, challenges in research and development, side-effects of treatment, the presence of misbranded and spurious drugs, expiration of patented drugs, and poor healthcare system in low and middle-income countries may hamper the growth of the market.

Segmentation

The global parathyroid disorders market is segmented on the basis of type, diagnosis, treatment, and end user.

On the basis of the type, the market is classified as hyperparathyroidism (HPT), parathyroid cancer, and hypoparathyroidism. The hyperparathyroidism is further sub-segmented into primary hyperparathyroidism, secondary hyperparathyroidism, and tertiary hyperparathyroidism.

On the basis of the diagnosis, the market is classified as blood tests, imaging tests, and urine tests. The imaging tests is further sub-segmented into CT or CAT (computed axial tomography) scans, MRI (magnetic resonance imaging) scans, X-ray, ultrasound, bone density test, and sestamibi scan.

On the basis of the treatment, the market is classified as surgery, radiation therapy, drugs, and others. The drugs segment is further sub-segmented into calcimimetics, hormone replacement therapy, and bisphosphonates.

On the basis of the end user, the market is segmented into hospitals & clinics, diagnostic centers, drug stores, pharmacies, and others.

Key Players

Some of the key players in the global parathyroid disorders market are Abbott Laboratories, Alcon Laboratories, Inc., Amgen Inc., Bayer Healthcare, Becton, Dickinson and Company, Eli Lilly, Ethicon, Inc., Genentech, Medtronic, Merck, Mylan Laboratories, Novartis, Novo Nordisk, Pfizer, Roche, Smith & Nephew plc, Stryker, Teva Pharmaceutical Industries Ltd., Zimmer Biomet Holdings, Inc., and others.

Regional Analysis:

The Americas dominate the global parathyroid disorders market owing to the rising prevalence of parathyroid disorders and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total healthcare expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.

Europe holds the second position in the parathyroid disorders market. It is expected that the support provided by the government bodies for research & development and improvement in the reimbursement policies in the healthcare is likely to drive the market of the European region.

The Asia Pacific is the fastest growing parathyroid disorders market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total healthcare expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.

The Middle East & Africa holds the least market share due to lack of technical knowledge and poor medical facilities.

Browse More Healthcare Related Research Reports at:

Needle Biopsy Market Size, Growth Analysis | Industry Trends, 2023

Bone Spur Market Share, Growth | Size Analysis, 2023

Fetal Macrosomia Market Trends, Application | Growth Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Pediatric Neurology Device Market Insights, Demand, Future Outlook And Applications

The Global Pediatric Neurology Devices Market Share, Application and Growth Analysis By Type (Neurostimulator, Others) Service & Treatment (Electroencephalogram, Others) Neurological Subspecialties (Stroke, Others) Age Group (Infants, Others) End User (Hospitals, Others) – Forecast till 2023

pediatric neurology device market share is expected to register approximately 6.3% CAGR between 2017 -2023, valuing exponentially by 2023. Common neurological disorders include stroke, Alzheimer’s disease, ADHD, epilepsy, headache, Parkinson’s disease, multiple sclerosis, sleep disorders, pain, brain, tremor, and spinal cord injuries, brain tumors, peripheral nervous disorders and amyotrophic lateral sclerosis occurring in children. Also, some not so serious issues such as seizures, delayed speech, poor muscle tone, or frequent headaches can be treated in pediatric neurology.

The pediatric neurology sector has been witnessing the emergence of many advent devices over the past few years that are offering effective outcomes. As a result, the global pediatric neurology device market is increasing pervasively. Factors such as the increasing prevalence of neurological disorders in children are fuelling the market growth to an extent. Also, the risk factors for these disorders are speeding up the market growth, creating the demand for the better diagnostic and treatment methods.

Additional factors substantiating the market growth include increasing governmental funding and programs especially in the developing regions to support the R&D activities undertaken for the invention of new devices.  Technological advancements that took place in the smart and connected devices and the proliferation of some ubiquitous technologies such as the Artificial Intelligence (AI) and Internet of Things (IoT) in the pediatric neurology devices foster the market growth.

Global Pediatric Neurology Device Market- Regional Analysis

Globally, North America is dominating the global pediatric neurology device market. Furthermore, factors such as extensive uptake of technologically advanced medical devices, increasing governmental support for R&D activities and high expenditures in the neurological care substantiate the market growth include.  With the growing prevalence of neurological disorders in children, the market is expected to evaluate phenomenally by 2023.

Europe region is another lucrative market for pediatric neurology device. Increasing focus on the development of advent diagnostic devices, rising government support for R&D activities is contributing to the market growth. Also, the increasing numbers of specialty services offered by various healthcare providers foster the growth of the market in the region.

The Asia Pacific is emerging as a promising market for pediatric neurology devices, growing rapidly.  Increasing incidents of neurological disorders are fuelling the market growth.  Moreover, factors such as the augmenting demand for quality devices in the healthcare and proliferating healthcare technology is projected to provide impetus to the market growth, leading to the increasing the uptake of advanced equipment.

Industry/Innovations/Related News:

October 4, 2018 – Dictum Health Inc., (US), innovators in telehealth’s Virtual Exam Room (VER) technology, and eMD Telehealth Solutions, a telehealth company, announced their collaborative launch of Dictum Health’s Care Central Telestroke Module in several regional hospitals to support local healthcare providers and patients with 24-hour access to neurologists including pediatric neurologists as well.

Browse More Healthcare Related Research Reports at:

UTI Treatment Market Size, Growth Analysis | Application, 2023

Electrotherapy Market Trends, Size Analysis | Share Value, 2023

Folliculitis Market Size, Growth Analysis | Industry Trends, 2023

About Market Research Future: 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com